DarioHealth Corp. (DRIO): Price and Financial Metrics
DRIO Price/Volume Stats
| Current price | $1.45 | 52-week high | $4.58 |
| Prev. close | $1.32 | 52-week low | $0.68 |
| Day low | $1.30 | Volume | 166,500 |
| Day high | $1.52 | Avg. volume | 136,938 |
| 50-day MA | $1.64 | Dividend yield | N/A |
| 200-day MA | $2.23 | Market Cap | 42.69M |
DRIO Stock Price Chart Interactive Chart >
DarioHealth Corp. (DRIO) Company Bio
DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Blood Glucose Monitoring System, a pocket-sized, blood glucose monitoring device. It offers DarioEngage software platform, where the company digitally engages with Dario users and assists them in monitoring their chronic illnesses, as well as provides them with coaching, support, digital communications; and real time alerts, trends, and pattern analysis. DarioHealth Corp. markets its products directly to consumer cash sales, as well as retail pharmacy, hospitals, and distributors; and through online. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is headquartered in Caesarea, Israel.
Latest DRIO News From Around the Web
Below are the latest news stories about DARIOHEALTH CORP that investors may wish to consider to help them evaluate DRIO as an investment opportunity.
National Employer Selects Dario Cardiometabolic and GLP-1 Solutions to Improve Employee HealthDarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract to provide cardiometabolic and GLP-1 solutions to a national employer (the "Employer") beginning in January 2024. |
Is It Too Late To Consider Buying DarioHealth Corp. (NASDAQ:DRIO)?DarioHealth Corp. ( NASDAQ:DRIO ), is not the largest company out there, but it led the NASDAQCM gainers with a... |
Blue Shield of California's Award-Winning Wellvolution Now More Accessible for Spanish Speakers, Adds New Hypertension OfferingBlue Shield of California is making its award-winning digital health platform Wellvolution more accessible for Spanish-speakers and expanding its program with the addition of Dario, an at-home solution for high blood pressure, or hypertension, that combines personalized health coaching and tech-enabled monitoring. |
Dario Contracts with New Employer for Cardiometabolic SolutionDarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract to provide its cardiometabolic solution to an employer (the "Employer") beginning in January 2024. |
New Research Sheds Light on Mediators of Improved Outcomes in Dario UsersDarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new analyses recently presented by Sanofi U.S. demonstrating two mediators associated with improved clinical and economic in Dario users. |
DRIO Price Returns
| 1-mo | -2.68% |
| 3-mo | -30.29% |
| 6-mo | 11.54% |
| 1-year | -55.66% |
| 3-year | -92.18% |
| 5-year | -90.59% |
| YTD | -15.70% |
| 2023 | -59.81% |
| 2022 | -67.00% |
| 2021 | -9.24% |
| 2020 | 117.84% |
| 2019 | -57.95% |
Continue Researching DRIO
Want to see what other sources are saying about DarioHealth Corp's financials and stock price? Try the links below:DarioHealth Corp (DRIO) Stock Price | Nasdaq
DarioHealth Corp (DRIO) Stock Quote, History and News - Yahoo Finance
DarioHealth Corp (DRIO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...